Anti-TNFSF7/CD27L/CD70 Antibody (Vorsetuzumab)
Catalog No.
F1867
Anti-TNFSF7/CD27L/CD70 Antibody (Vorsetuzumab)
Featured Products
Vorsetuzumab is a CHO-expressed humanized antibody targeting TNFSF7/CD27L/CD70.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.1 kDa
Dry ice
1165740-62-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
SGN-70, H1F6
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P32970
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized humanCD70-His at 2 μg/mL (30 μL/well) can bind Vorsetuzumab(P98623) with the EC50 of 0.001164 μg/mL.
TNFSF7 / CD27L / CD70
Please avoid freeze-thaw cycles.